A numbers limit does not fit with the government’s “objectives for pharmacy” and students will benefit from “greater choice” without it, says universities minister Greg Clark
Better safe and sorry
The GMC is consulting on strengthening professional sanctions on doctors, so will the GPhC be following in its footsteps? Almost certainly, says solicitor Philippa Doyle
The student number conundrum
Extensive consultation and debate has shown support for a cap on pharmacy school intakes, so why is the government leaving student numbers uncontrolled?
9 ways to improve your relationship with GPs
C+D asked three pharmacists who have successfully collaborated with their primary care counterparts for their top tips on working with GPs
Category M Barometer
October 2014 Reimbursement will increase by 6.7 per cent in the final quarter of 2014, which sees an extra £31.7 million added to the category M pot
Boots and the PDA: The never-ending story
Will the long-running legal battle between the multiple and the PDA Union ever come to an end and, if so, what will be the outcome be?
The C+D Salary Survey needs you
Emma Weinbren talks to News Editor James Waldron about the launch of the latest Salary Survey
Pharmacists accused of illegally selling prescription medicines by a BBC investigation two years ago are finally facing professional sanctions – so has the scandal been handled proportionately?
Update Module 1723 This module covers the incidence, causes and symptoms of angina, treatment of stable angina and secondary prevention measures
A patient with diabetes, hypertension and other issues is getting severe cramp when walking. Could his statin be the cause?
A young woman is concerned that she may have a sexually transmitted infection. Is she right or could it be another condition?
Job of the week
Follow C+D Jobs on
C+D Salary Survey 2013 Given the scale of the challenges facing pharmacists today, the results of this year's investigation are unsurprising – but they are still a cause for concern
NHS England is hopeful that pharmacists will contribute to "a conversation" on how healthcare should change
It is "of vital importance" that manufacturers communicate with regulatory bodies, says BAPW executive director Martin Sawer
Nothing ever seems to happen quickly in pharmacy, says Jennifer Richardson, but there are some areas where progress is being made